by Andreas Kremer | Sep 9, 2024
The collaboration is pioneering multidisciplinary work of 32 partners that will provide a 360º vision on how to advance healthcare applications through Synthetic Data use. We will tackle the critical need for privacy-preserving data solutions in healthcare by...
by Andreas Kremer | Mar 11, 2024
A Cellular Immunotherapy Virtual Twin for Personalised Cancer Treatment Our journey with CERTAINTY is driven by a simple fact: while CAR T cell therapy has worked wonders for many, it is still unclear why some patients do not respond to therapy. Some patients see...
by Andreas Kremer | Jun 16, 2023
Luxembourg, June 14th 2023. Today a consortium of public and private entities announced the official launch of IDERHA (Integration of heterogenous Data and Evidence towards Regulatory & HTA Acceptance). The consortium aims to propel health care innovation in...
by Andreas Kremer | Jun 1, 2022
EU-PEARL is a strategic partnership between the public and private sectors to shape the future of clinical trials. This innovative and challenging enterprise aims to create a framework for patient-centric integrated research platform (IRP) trials, through which novel...
by Andreas Kremer | Nov 15, 2021
OPTIMA aims to harness the power of artificial intelligence, to advance treatments and facilitate decision-making for physicians and patients with prostate, breast and lung cancer. At the heart of OPTIMA will be Europe’s first interoperable, large scale oncology data...
